Equifax (EFX) Stock
Global consumer credit reporting giant selling data and analytics. Here's the price, business snapshot, and what's worth knowing about Equifax in September 2026.
Equifax Inc (EFX) is a global consumer credit reporting and analytics firm that collects and sells data, scoring models and identity-protection services to businesses and consumers. Investors often note its recurring revenue from subscription-style services and analytics, which can provide cashflow visibility; the company also benefits from data-driven trends such as digital lending and fraud prevention. Key issues to watch include regulatory and legal risks tied to data privacy and accuracy, plus the operational need to maintain robust cybersecurity after past high-profile breaches. Equifax’s performance can be influenced by credit-cycle dynamics — tougher credit conditions may reduce some client activity while raising demand for risk analytics. This summary is general educational information, not personalised financial advice; values can fall as well as rise and prospective investors should assess whether the stock fits their own risk profile and objectives.
Why It’s Moving
Equifax Accelerates AI-Driven Product Expansion with New Fraud and Healthcare Solutions
- The company unveiled Signal Score for Email and Signal Score for Device, enabling businesses to detect account takeovers and synthetic fraud in real time.
- A new Healthcare Report Credential ID solution was introduced to streamline provider onboarding and safeguard patient care through automated screening.
- Growth outlook remains supported by rising demand for Workforce Solutions and broad-based international revenue gains, alongside cost savings from AI integration.
Equifax Accelerates AI-Driven Product Expansion with New Fraud and Healthcare Solutions
- The company unveiled Signal Score for Email and Signal Score for Device, enabling businesses to detect account takeovers and synthetic fraud in real time.
- A new Healthcare Report Credential ID solution was introduced to streamline provider onboarding and safeguard patient care through automated screening.
- Growth outlook remains supported by rising demand for Workforce Solutions and broad-based international revenue gains, alongside cost savings from AI integration.
Sixth Month Growth Performance
When is the next earnings date for EQUIFAX INC (EFX)?
Equifax (NYSE: EFX) is currently expected to release its next earnings report on October 20, 2026. The report will cover the third quarter of fiscal 2026. The date remains an estimate pending formal confirmation, but it aligns with Equifax’s established late-October reporting pattern.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Equifax's stock, expecting it to rise significantly in value.
Financial Health
Equifax is showing strong revenue and cash flow, indicating solid business performance and financial health.
Dividend
Equifax's dividend yield of 1.33% is low, indicating limited returns for dividend-seeking investors. If you invested $1000 you would be paid $13.20 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Data-driven revenue
Subscription and analytics services can create predictable revenue streams, supporting cashflow — though performance varies with client demand and the economic cycle.
Global footprint matters
Operations in multiple markets diversify income but increase regulatory complexity and the need to comply with varied data-privacy laws.
Cybersecurity focus
Given the sensitivity of data, security investments and compliance are central; breaches or regulatory fines can materially affect reputation and results.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
